S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
NYSE:VAPO

Vapotherm (VAPO) Stock Price, News & Analysis

$1.36
0.00 (0.00%)
(As of 04/16/2024 ET)
Today's Range
$1.36
$1.38
50-Day Range
$0.87
$1.60
52-Week Range
$0.75
$7.44
Volume
834 shs
Average Volume
9,729 shs
Market Capitalization
$8.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VAPO stock logo

About Vapotherm Stock (NYSE:VAPO)

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

VAPO Stock Price History

VAPO Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Vapotherm: Q4 Earnings Snapshot
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
OTC Markets Group Welcomes Vapotherm, Inc. to OTCQX
Vapotherm Reports Third Quarter 2023 Financial Results
Earnings Outlook For Vapotherm
Vapotherm To Report Third Quarter 2023 Financial Results
Vapotherm Shares Jump on Positive Asthma Therapy Study
See More Headlines
Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/16/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Fax
N/A
Employees
182
Year Founded
N/A

Profitability

Net Income
$-58,190,000.00
Pretax Margin
-84.56%

Debt

Sales & Book Value

Annual Sales
$68.67 million
Book Value
($9.01) per share

Miscellaneous

Free Float
5,221,000
Market Cap
$8.43 million
Optionable
Optionable
Beta
-1.11
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Joseph F. Army CPA (Age 60)
    CEO, President & Director
    Comp: $575k
  • Mr. John LandryMr. John Landry (Age 51)
    Senior VP, CFO & Treasurer
    Comp: $593.38k
  • Mr. Brian Lawrence (Age 54)
    Senior VP & CTO
    Comp: $587.13k
  • Mr. William Niland
    Founder
  • Ms. Dorota Mckay (Age 41)
    VP, Controller & Chief Accounting Officer
  • Mr. Anthony Ten Haagen
    Vice President of Legal & Compliance
  • Mr. James A. Lightman (Age 66)
    Senior VP, General Counsel & Secretary
  • Ms. Lindsay Becker (Age 39)
    Vice President of Human Resources
  • Dr. Jessica Whittle M.D.
    Ph.D., Chief Medical Officer & VP of Clinical Research

VAPO Stock Analysis - Frequently Asked Questions

How have VAPO shares performed in 2024?

Vapotherm's stock was trading at $1.00 on January 1st, 2024. Since then, VAPO shares have increased by 36.0% and is now trading at $1.36.
View the best growth stocks for 2024 here
.

When is Vapotherm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our VAPO earnings forecast
.

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) released its quarterly earnings data on Thursday, February, 22nd. The company reported ($1.60) EPS for the quarter. The company earned $19.73 million during the quarter.

When did Vapotherm's stock split?

Vapotherm shares reverse split before market open on Friday, August 18th 2023. The 1-8 reverse split was announced on Friday, August 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What is Joe Army's approval rating as Vapotherm's CEO?

65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Block (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and

When did Vapotherm IPO?

Vapotherm (VAPO) raised $60 million in an initial public offering on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Vapotherm?

Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:VAPO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners